Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar;71(3):11-12.
doi: 10.5005/japi-11001-0214.

Role of Iron Therapy in Heart Failure: A Consensus Statement from India

H K Chopra  1 , G S Wander  2 , Tiny Nair  3 , C K Ponde  4 , Navin C Nanda  5 , Jagat Narula  6 , Saumitra Ray  7 , K Venugopal  8 , S S Iyengar  9 , R R Kasliwal  10 , Praveen Chandra  11 , Sunil Prakash  12 , Sandeep Bansal  13 , D S Rana  14 , Prafulla Kerkar  15 , Arup Dasbiswas  16 , Jps Sawhney  17 , S Shanmungasundram  18 , Viveka Kumar  19 , I B Vijayalakshmi  20 , A K Pancholia  21 , Vinod Sharma  22 , Aditya Kapoor  23 , Onkar C Swami  24 , H S Isser  25 , Vishal Rastogi  26 , Y K Arora  27 , Ashok K Omar  28 , Sunil Sathe  29 , Rajeeve Rajput  30 , D Prabhakar  31 , G J Paul  32 , Priya Jagia  33 , Poonam Malhotra  34 , G Suryaprakash  35 , Vinod Mittal  36 , Manish Jagia  37 , A Jabir  38 , S S Mishra  39 , S N Routray  40 , Ajay K Sinha  41 , Mohan Bhargava  42 , Kiran Mahmood  43 , Mona Bhatia  44 , Pramila Kalra  45 , V K Katyal  46 , Rohit Tandon  47 , Rahul Grover  48 , Abhinav Chhabra  49 , N R Shastry  50
Affiliations

Role of Iron Therapy in Heart Failure: A Consensus Statement from India

H K Chopra et al. J Assoc Physicians India. 2023 Mar.

Abstract

Iron deficiency (ID) with or without anemia is frequently observed in patients with heart failure (HF). Uncorrected ID is associated with higher hospitalization and mortality in patients with acute HF (AHF) and chronic HF (CHF). Hence, in addition to chronic renal insufficiency, anemia, and diabetes, ID appears as a novel comorbidity and a treatment target of CHF. Intravenous (IV) ferric carboxymaltose (FCM) reduces the hospitalization risk due to HF worsening and improves functional capacity and quality of life (QOL) in HF patients. The current consensus document provides criteria, an expert opinion on the diagnosis of ID in HF, patient profiles for IV FCM, and correct administration and monitoring of such patients.

PubMed Disclaimer

Publication types